FULC
FULC
NASDAQ · Pharmaceuticals

Fulcrum Therapeutics Inc

$3.71
-0.06 (-1.59%)
As of Nov 7, 2:00 AM ET ·
Analyst Consensus
Sell
11
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 64%
Sell 4 36%
Price Target
Analyst Price Target +1,435.8% upside
Low Target $37.54
Average Target $56.98
High Target $60.88
Current Price $3.71
Current
$3.71
Target
$56.98
$37.54 $56.98 avg $60.88
Scenario Analysis
Bear Case
$37.54
911.9%
Low target
Base Case
$56.98
+1,435.8%
Avg target
Bull Case
$60.88
+1,541.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$15.74
-76.4% from high
52-Week Low
$2.83
+31.1% from low
Target vs 52W High
$56.98
+262.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%